OTC:APTN | Cash Flow Statement | ADAPTIN BIO, INC.

Complete source-backed cash-flow history.

Available history
2022-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.21M
2026-03-31-$1.15M-$596,298.00$438,433.00
2025-12-31-$1.37M-$702,876.00$582,961.00
2025-09-30-$1.68M
2025-06-30-$1.52M
2025-03-31-$603,084.00-$2.28M$4.62M
2024-12-31-$856,836.00$112,653.00-$193,876.00
2024-09-30-$1.11M
2024-06-30-$818,738.00
2024-03-31-$339,432.00-$89,695.00$90,000.00
2023-12-31-$34,155.00-$58,347.00$58,347.00
2023-09-30-$42,938.00
2023-06-30-$4,250.00
2023-03-31-$4,250.00
2022-09-30-$4,250.00
2022-06-30-$4,250.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$5.17M-$4.78M$5.2M
2024-12-31-$3.12M-$649,283.00$678,614.00
2023-12-31-$85,593.00-$81,035.00$80,915.00